Free Delivery Over $100
|
|
|||
|
||||
OverviewThe pharmaceutical industry is in a dire situation: R&D still produces no more drugs than 10 years ago, while costs have quadrupled in the meantime. Little advances have been made in innovation efficiency. Worse yet, drug development times are unacceptably long, possible drug development targets are waning, and national healthcare is tightening the cost squeeze. A predictable and efficient pipeline of drug candidates, coupled with a handful of blockbuster drugs, is considered the Holy Grail of pharmaceutical innovation. In this book, the authors develop a case for mastering pharmaceutical innovation focusing on three leading sources of future pharmaceutical competitiveness: new technologies and techniques, better pipeline management, and stronger integration of external innovation. Illustrated with plenty of real-life cases, this book tells you how to put the principles of leading pharmaceutical innovation into practice. Full Product DetailsAuthor: Oliver Gassmann , Gerrit Reepmeyer , Maximilian von ZedtwitzPublisher: Springer-Verlag Berlin and Heidelberg GmbH & Co. KG Imprint: Springer-Verlag Berlin and Heidelberg GmbH & Co. K Dimensions: Width: 16.50cm , Height: 1.30cm , Length: 24.10cm Weight: 0.399kg ISBN: 9783540407171ISBN 10: 3540407170 Pages: 189 Publication Date: 12 January 2004 Audience: General/trade , General Format: Hardback Publisher's Status: Active Availability: Out of stock  The supplier is temporarily out of stock of this item. It will be ordered for you on backorder and shipped when it becomes available. Table of ContentsInnovation as a Key Success Factor in the Pharmaceutical Industry.- Pharmaceutical Innovation: The Case of Switzerland.- The Science and Technology Challenge: How to Find New Drugs.- The Pipeline Management Challenge: How to Shape the Innovation Flow.- The Outsourcing and Internationalization Challenge: How to Harness Outside Innovation.- Management Answers to Pharmaceutical R&D Challenges.- Future Directions and Trends.- Appendix.ReviewsFrom the reviews: This book examines the international pharmaceutical industry with special emphasis on the current and emerging research methodologies a ] . What distinguishes this book from others on the same subject is its emphasis on empirical findings (53 figures, 20 tables) and an exceptionally good, if short, discussion of various research technologies a ] . The six-page glossary of industry terms, when used with its decent index, is a particular joy. a ] recommend this offering to prospective managers and researchers in this industry a ] . (Robert R. Rothberg, Journal of Product Innovation Management, Vol. 22, 2005) From the reviews: <p> This book examines the international pharmaceutical industry with special emphasis on the current and emerging research methodologies a ] . What distinguishes this book from others on the same subject is its emphasis on empirical findings (53 figures, 20 tables) and an exceptionally good, if short, discussion of various research technologies a ] . The six-page glossary of industry terms, when used with its decent index, is a particular joy. a ] recommend this offering to prospective managers and researchers in this industry a ] . (Robert R. Rothberg, Journal of Product Innovation Management, Vol. 22, 2005) Author InformationTab Content 6Author Website:Countries AvailableAll regions |
||||
